Desarrollo de neoplasia en pacientes con enfermedad inflamatoria intestinal

Keyphrases

• Inflammatory Bowel Disease 100%
• Tumor 100%
• Malignant Tumor 100%
• Immunosuppressive Therapy 50%
• Chronic Myeloid Leukemia 50%
• Clinical Features 25%
• Chronic Inflammation 25%
• Colorectal Cancer 25%
• Disease Severity 25%
• Demographic Characteristics 25%
• Private Clinic 25%
• Median Time 25%
• Retrospective Analysis 25%
• Ulcerative Colitis 25%
• Neoplasia 25%
• Extraintestinal Manifestations 25%
• Biological Therapy 25%
• Cancer Risk 25%
• Mesalamine 25%
• Intestinal mucosa 25%
• Immunosuppressive Medication 25%
• Patient Registry 25%
• IBD Patients 25%
• Cancer Diagnosis 25%
• Non-melanoma Skin Cancer 25%
• Hypernephroma 25%
• Cholangiocarcinoma 25%

Medicine and Dentistry

• Malignant Neoplasm 100%
• Inflammatory Bowel Disease 100%
• Patient with Inflammatory Bowel Disease 100%
• Neoplasm 83%
• Disease 33%
• Immunosuppressive Treatment 33%
• Chronic Myelogenous Leukemia 33%
• Drug Therapy 16%
• Azathioprine 16%
• Clinical Feature 16%
• Immunosuppressive Drug 16%
• Biological Therapy 16%
• Ulcerative Colitis 16%
• Cancer Diagnosis 16%
• Chronic Inflammation 16%
• Cancer Risk 16%
• Mesalazine 16%
• Intestine Mucosa 16%
• Colorectal Carcinoma 16%
• Patient Registry 16%
• Cholangiocarcinoma 16%
• Kidney Carcinoma 16%
• Non Melanoma Skin Cancer 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Inflammatory Bowel Disease 100%
• Malignant Neoplasm 100%
• Neoplasm 71%
• Immunosuppressive Agent 42%
• Disease 28%
• Chronic Myeloid Leukemia 28%
• Clinical Feature 14%
• Ulcerative Colitis 14%
• Azathioprine 14%
• Aminosalicylic Acid 14%
• Bile Duct Carcinoma 14%
• Patient Registry 14%
• Kidney Carcinoma 14%
• Non Melanoma Skin Cancer 14%
• Chronic Inflammation 14%
• Colorectal Carcinoma 14%